Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tesaglitazar add-on to sulphonylurea in T2D (GALLANT 7)
NCT00251940Phase 3Terminated
- Sponsor
- AstraZeneca
- Start
- Jul 2004
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of tesaglitazar in type 2 diabetes mellitus (T2DM), sponsored by AstraZeneca. Started Jul 2004; status: terminated.
02
Drugs
tesaglitazar
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00251940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00251940.